Journal Mobile Options
Table of Contents
Vol. 16, Suppl. 1, 2007
Issue release date: August 2007
Section title: Review

Open Access Gateway

Med Princ Pract 2007;16:3–9
(DOI:10.1159/000104540)

Management of Non-Pain Symptoms in Pediatric Palliative Care

Friedrichsdorf S.J. · Collins J.J.
aPain and Palliative Care Service, Children’s Hospital at Westmead, Sydney, Australia; bPain and Palliative Care Department, Children’s Hospitals and Clinics of Minnesota, Minneapolis, Minn., USA

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Abstract

The majority of children dying from a life-limiting condition suffer from distressing symptoms during their last weeks of life. The provision of current state-of-the-art symptom control is paramount for any health care professional working with dying children, but treatment guidelines are sparse. This article reviews the management of integrative and pharmacological therapies for acute seizure control, anorexia, death rattle, dyspnea, nausea and vomiting, and muscle spasm during the end-of-life period of children and teens. Several myths and misconceptions have led to inadequate symptom control in children with a terminal disease. A dying child is often highly symptomatic, and providing professional integrative and pharmacological symptom relief is one of the many precincts of pediatric palliative care.


  

Author Contacts

Stefan J. Friedrichsdorf, MD
Pain and Palliative Care Department, Children’s Hospitals and Clinics of Minnesota
2525 Chicago Avenue South, Minneapolis, MN 55404 (USA)
Tel. +1 612 813 6100, Fax +1 612 813 6358
E-Mail stefan.friedrichsdorf@childrensmn.org

  

Article Information

The authors have made extensive efforts to ensure that treatments, drugs and dosage regimens in this article are accurate and conform to the standards accepted at the time of the publication. However, changes in information through continuing research and clinical experience and the possibility of human error warrant that the authors do not accept any responsibility for any loss or damage arising from actions or decisions based on information in this article: the ultimate responsibility for the treatment of patients and interpretation of published material lies with the medical practitioner. There are standard on-line references for current dosing information and one of these should be consulted.

Received: June 29, 2005
Revised: February 6, 2006
Number of Print Pages : 7
Number of Figures : 0, Number of Tables : 3, Number of References : 31

  

Publication Details

Medical Principles and Practice (International Journal of the Kuwait University Health Sciences Centre)

Vol. 16, No. Suppl. 1, Year 2007 (Cover Date: August 2007)

Journal Editor: Owunwanne, A. (Kuwait)
ISSN: 1011–7571 (print), 1423–0151 (Online)

For additional information: http://www.karger.com/MPP


Article / Publication Details

First-Page Preview
Abstract of Review

Received: 6/29/2005
Accepted: 2/6/2006
Published online: 8/17/2007

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 3

ISSN: 1011-7571 (Print)
eISSN: 1423-0151 (Online)

For additional information: http://www.karger.com/MPP


Open Access License / Drug Dosage

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.